Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

WILPO

PHENTERMINE HYDROCHLORIDE

Standard Dose
8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview WILPO is listed in Drugs@FDA under application 012737 (NDA).

Marketing status: Discontinued Active ingredient PHENTERMINE HYDROCHLORIDE Form and strength TABLET;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SANDOZ Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview WILPO is listed in Drugs@FDA under application 012737 (NDA). Marketing status: Discontinued Active ingredient PHENTERMINE HYDROCHLORIDE Form and strength TABLET;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SANDOZ Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
WILPO (PHENTERMINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline